Summit Therapeutics Inc. (SMMT) › Weighted Average Diluted SharesSummit Therapeutics Inc. (SMMT) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2019-01-31: 17.23M2020-12-31: 69.52M2021-12-31: 131.71M2022-12-31: 193.34M2023-12-31: 619.65M2024-12-31: 718.54M2025-12-31: 747.70M747.70M2019-01-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31747.70M+4.1%2026-02-23From 2025-01-012024-12-31718.54M+16.0%2026-02-23From 2024-01-012023-12-31619.65M+220.5%2026-02-23From 2023-01-012022-12-31193.34M+46.8%2025-02-24From 2022-01-012021-12-31131.71M+89.5%2023-03-09From 2021-01-012020-12-3169.52M—2022-12-21From 2020-01-012019-01-3117.23M—2021-03-31From 2018-02-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)